"Safety & Efficacy of Cyclophosphamide plus Total Body Irradiation with Post-Transplant Cyclophosphamide for Allogeneic Hematopoietic Stem Cell Transplantation"
"Predictability of Methicillin-Resistant Staphylococcus Aureus Nasal Swabs in Adult and Pediatric Oncology"
Speakers:
Ryan Lozano, PharmD, PGY2 Hematology/Oncology Pharmacy Resident - has nothing to disclose.
Dominick Patafio, PharmD, PGY2 Hematology/Oncology Pharmacy Resident - has nothing to disclose.
Moderator:
Tristan Maiers, PharmD, BCOP, PGY2 Oncology Residency Program Director, Geisinger - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
- Review the background of allogeneic stem cell transplants
- Describe the purpose and methods used in the transplant study
- Discuss study results and implications of the transplant study
- Describe the current literature surrounding the clinical utility of the MRSA nasal swab
- Determine the negative predictive value of the MRSA nasal swab in oncology patients with febrile neutropenia
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Tristan Maiers, PharmD, BCOP; Rajiv Panikkar, MD; Michele Long, BSN; Jaime Weeder, NP and Christopher Kashi, PA-C have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose.
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPAA compliant.
Commercial Support for this Session
None
- 1.00 AAPA Category I CME
- 1.00 ACPE
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation Credit

Facebook
X
LinkedIn
Forward